Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

Sour Grapes are free with the Ripple Wine for BTH Long-Hal-ers.
A stronger presentation from the CEO with possibilities and plans would have been nice. Something like a comparison with what Rem received EUA for, maybe.
The Nail is the 40mg question, IPF plan?, new VP introduction with answers that most of us could do better with, no carrot of even 3rd world partnerships for Phase 3.

682 patients was the CT full enrollment target for both Phase2b and 3 combined. Maybe Amg gets the New* to answer to that.
AGN continues to pull de-feet from possible success.
A lot is in the (prepared?) presentation. IMO this sucked and held little hope for investor's future...GLTA...